Navigation Links
New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma

Raleigh, NC (PRWEB) July 14, 2014

The NIH is giving $8 million dollars to researchers at the University of Pennsylvania to fund a clinical trial on light-based therapy in mesothelioma surgical patients. Click here to read Surviving Mesothelioma’s newly-posted article on the research.

Scientists at the University of Pennsylvania plan to use the grant to enroll 102 pleural mesothelioma study participants over the next four years. Patients will receive a photosensitizing drug prior to surgery. Then half will have the laser light treatment during their procedure while half will have only follow-up chemotherapy.

“This trial represents a major step in understanding the combination of treatment modalities that will offer patients the best hope for survival and extended remission,” said lead investigator Eli Glatstein, MD.

Previous University of Pennsylvania studies of PDT with lung-sparing surgery have produced remarkable survival rates of up to 41 months, even in patients with advanced mesothelioma.

“PDT is an exciting emerging therapy that is currently not widely available for mesothelioma treatment,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “If the results of these new NIH-funded studies are as encouraging as the previous studies of PDT at Penn, more patients who need it may get access to this therapy.”

For details of the new PDT research at Penn, see NIH Grant May Help Validate Light-Based Therapy for Mesothelioma now available on the Surviving Mesothelioma website.

“Penn Mesothelioma Program Receives $8 Million NCI Grant to Study Effects of Photodynamic Therapy Plus Surgery on Patient Survival and Disease Progression”, July 10, 2014, News Release, University of Pennsylvania website,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stanford researchers invent nanotech microchip to diagnose type-1 diabetes
2. Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld
3. Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at
4. Casinos in Australia Industry Market Research Report Now Updated by IBISWorld
5. Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated
6. World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at
7. Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld
8. Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld
9. Researchers Assess New Way to Boost Polio Immunity
10. USC stem cell researcher targets the seeds of breast cancer metastasis
11. Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: